| RWMHX | TRLIX | RWMHX / TRLIX | |
| Total Expense Ratio | 0.41 | 0.41 | 100% |
| Annual Report Gross Expense Ratio | 0.41 | 0.41 | 100% |
| Fund Existence | 10 years | 23 years | - |
| Gain YTD | 2.169 | 3.649 | 59% |
| Front Load | N/A | N/A | - |
| Min. Initial Investment | 250 | 1000000 | 0% |
| Min. Initial Investment IRA | N/A | N/A | - |
| Net Assets | 208B | 6.38B | 3,261% |
| Annual Yield % from dividends | 1.38 | 1.59 | 87% |
| Returns for 1 year | 9.89 | 12.76 | 77% |
| Returns for 3 years | 31.32 | 31.22 | 100% |
| Returns for 5 years | 39.60 | 37.07 | 107% |
| Returns for 10 years | 101.22 | 92.00 | 110% |
| 1 Day | |||
|---|---|---|---|
| ETFs / NAME | Price $ | Chg $ | Chg % |
| BBC | 41.49 | 1.67 | +4.19% |
| Virtus LifeSci Biotech Clinical Trls ETF | |||
| KXI | 66.96 | 0.76 | +1.15% |
| iShares Global Consumer Staples ETF | |||
| VTV | 197.68 | 1.09 | +0.55% |
| Vanguard Value ETF | |||
| AFIF | 9.45 | N/A | -0.05% |
| Anfield Universal Fixed Income ETF | |||
| DMAX | 26.67 | -0.03 | -0.12% |
| iShares Large Cap Max Buffer Dec ETF | |||